Preliminary Results of the Combination of Bevacizumab and Weekly Paclitaxel in Advanced Melanoma

Publisher： Karger

E-ISSN： 1423-0232|74|1-2|12-16

ISSN： 0030-2414

Source： Oncology, Vol.74, Iss.1-2, 2008-06, pp. : 12-16

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Weekly Paclitaxel and Carboplatin Combination Chemotherapy in Patients with Advanced Squamous Cell Carcinoma of the Head and Neck

By  

Oncology Research and Treatment, Vol. 26, Iss. 6, 2004-01 ,pp. : 568-572

Karger

Access to resources Recommend Favorite

Phase I Study of a Combination of S-1 and Weekly Paclitaxel in Patients with Advanced or Recurrent Gastric Cancer

By  

Oncology, Vol. 69, Iss. 3, 2005-10 ,pp. : 261-268

Karger

Access to resources Recommend Favorite

Phase I/II Study of a Combination of S-1 and Weekly Paclitaxel in Patients with Advanced or Recurrent Gastric Cancer

By  

Oncology, Vol. 72, Iss. 3-4, 2008-01 ,pp. : 219-225

Karger

Access to resources Recommend Favorite

Complete Remission of Metastatic and Relapsed Uterine Cervical Cancers Using Weekly Administration of Bevacizumab and Paclitaxel/Carboplatin

By  

Oncology Research and Treatment, Vol. 32, Iss. 10, 2009-09 ,pp. : 595-597

Karger

Access to resources Recommend Favorite

Docetaxel in Combination with Dacarbazine in Patients with Advanced Melanoma

By  

Oncology, Vol. 63, Iss. 4, 2002-11 ,pp. : 333-337

Karger

Access to resources Recommend Favorite